Live Analyst Rating Changes 36623 upgrades, downgrades & price-target moves Β· freshest Wall Street data, updated daily View live feed β†’
Analyst Tracker/Charles Pitman CFA
BARC

Charles Pitman CFA

Wall Street Analyst
β˜…β˜…β˜…β˜…β˜†
#885
on 13Foresight Β· ranked by our own returns
74%
Success Rate
+5.3%
Average Return
34 of 46 calls profitable Β· +1.1% vs benchmark
S&P 500 (SPY)
πŸ”’ 5-year track record is Pro. Showing 1-year β€” upgrade.
πŸ“ˆ Across the calls we could measure, roughly 74% of Charles Pitman CFA's ratings turned a profit when each position was held for 1 year β€” averaging +5.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

79 Buy 35 Hold 9 Sell
Charles's Stock Coverage 21 ratings Β· 2026-10-03
Company Date Position Consensus β“˜ Price Target β“˜ 1-Yr Return vs S&P 500 β“˜
GB:0NZT
UCB SA
Oct 02, 2026 HOLD Strong Buy
+9.1% avg upside
19 analysts
$260.00
26.93% Upside
Β· Β·
DE:SRT3
Sartorius
Sep 30, 2026 BUY Strong Buy
+13.1% avg upside
19 analysts
$310.00
23.33% Upside
+0.2% Β·
FR:DIM
Sartorius Stedim Biotech
Sep 30, 2026 BUY Strong Buy
+24.1% avg upside
12 analysts
$250.00
20.00% Upside
+1.0% Β·
FR:IPN
Ipsen
Sep 28, 2026 SELL Hold
-10.3% avg upside
17 analysts
$145.00
3.87% Upside
+2.5% Β·
CH:LONN
Lonza Group Ltd
Sep 28, 2026 BUY Strong Buy
+14.9% avg upside
21 analysts
$730.00
29.02% Upside
-3.1% Β·
GB:0MGB
Genmab A/S
Sep 08, 2026 BUY Strong Buy
-7.9% avg upside
25 analysts
$2900.00
28.45% Upside
Β· Β·
CH:PPGN
PolyPeptide Group AG
Sep 08, 2026 HOLD Hold
-17.4% avg upside
3 analysts
$44.31
0.55% Upside
+0.2% Β·
CH:BANB
Bachem Holding AG
Sep 08, 2026 HOLD Sell
-4.4% avg upside
4 analysts
$80.00
0.95% Upside
+5.0% Β·
DE:MRK
Merck KGaA
Sep 08, 2026 HOLD Buy
+2.1% avg upside
34 analysts
$150.00
9.65% Upside
+3.2% Β·
DE:BAYN
Bayer
Sep 08, 2026 BUY Buy
+20.9% avg upside
31 analysts
$70.00
55.77% Upside
-8.8% Β·
IT:DIA
DiaSorin S.p.A.
Sep 07, 2026 SELL Hold
+45.9% avg upside
10 analysts
$70.00
6.52% Downside
-1.7% Β·
FR:BIM
bioMerieux
Sep 07, 2026 HOLD Hold
+29.1% avg upside
12 analysts
$80.00
4.31% Upside
+6.5% Β·
IT:REC
Recordati Industria Chimica e Farmaceutica SPA
Jul 30, 2026 HOLD Buy
-1.5% avg upside
9 analysts
$50.00
4.94% Downside
+2.7% Β·
ES:GRF
Grifols
Apr 22, 2026 BUY Hold
+52.4% avg upside
13 analysts
$12.50
31.18% Upside
+8.2% Β·
CH:SDZ
Sandoz Group Ltd
Mar 11, 2026 HOLD Strong Buy
-0.9% avg upside
12 analysts
$75.00
9.45% Upside
+12.6% Β·
GB:DIA
Dialight
Jan 06, 2026 SELL Strong Sell
1 analyst
β€” -63.6% Β·
BAYRY
Bayer
Jan 06, 2026 BUY Buy
+225.1% avg upside
9 analysts
β€” +30.4% Β·
GB:0QW0
arGEN X
Oct 31, 2025 BUY Strong Buy
-23.6% avg upside
25 analysts
$850.00
4.24% Upside
Β· Β·
ARGX
Argenx Se
Apr 28, 2025 BUY Strong Buy
-10.5% avg upside
48 analysts
$730.51
20.43% Downside
+24.8% Β·
GRFS
Grifols SA
Jan 04, 2024 BUY Buy
+222.6% avg upside
13 analysts
$20.23
176.75% Upside
-32.1% Β·
ABBV
AbbVie
Jan 13, 2022 BUY Strong Buy
-7.2% avg upside
47 analysts
β€” +19.4% Β·
πŸ”’ 16 more ratings β€” with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Charles Pitman CFA β€” Frequently Asked Questions
How accurate are Charles Pitman CFA's stock ratings?
Based on the calls 13Foresight could measure, about 74% of Charles's ratings were profitable over a one-year hold, with an average return of +6.1% per rating, or +38.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Charles ranked on 13Foresight?
Charles Pitman CFA is currently ranked #885 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge β€” so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Charles cover?
Charles most recently has ratings on GB:0NZT, DE:SRT3, FR:DIM, FR:IPN, CH:LONN, GB:0MGB, CH:PPGN, CH:BANB, DE:MRK, DE:BAYN, IT:DIA, FR:BIM and 9 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.